Lifecore Biomedical, Inc. cash flow to debt ratio of -0.14% indicates that the company cannot generate enough cash to cover its debt over time. This level indicates weak financial health.

Lifecore Biomedical, Inc.'s free cash flow has increased -24.90% from $-18.14M last year to $-13.62M, signaling increasing performance

Lifecore Biomedical, Inc.'s debt to equity ratio is 9.64, which means that the company's assets are unhealthy financed, signaling financial risk.

Lifecore Biomedical, Inc.'s debt has decreased relative to shareholder equity from 11.81 last year to 9.64 today, signaling strengthened financials

Lifecore Biomedical, Inc. has negative EBITDA, making leverage ratio unreliable

Lifecore Biomedical, Inc.'s interest coverage ratio is -0.09, which means that the company struggles to meet interest obligations, signaling financial risk.

Lifecore Biomedical, Inc.'s profit margin has decreased (424.59%) in the last year from 9.37% to -30.40%, signaling decreasing performance

Lifecore Biomedical, Inc.'s short-term assets of $82.29M exceed its short-term liabilities of $23.57M

Lifecore Biomedical, Inc.'s return on assets of 0.00% is lower than the 5.00% threshold, indicating inefficient asset utilization

Lifecore Biomedical, Inc.'s return on equity of -250.83%, is lower than 15.00%, indicating bad performance

Lifecore Biomedical, Inc.'s operating cash flow is lower than its net income, indicating that earnings may not be fully backed by cash generation

Lifecore Biomedical, Inc. had positive net income in only 1 out of 5 years, indicating unstable earnings

Lifecore Biomedical, Inc. has negative free cash flow, indicating the company is burning cash rather than generating it

Lifecore Biomedical, Inc. has negative free cash flow, indicating cash burn

Lifecore Biomedical, Inc.'s yearly earnings has decreased 422.29% since last year from $12.01M to $-38.72M, signaling decreasing performance

Lifecore Biomedical, Inc.'s yearly revenue has increased 0.46% since last year from $128.87M to $129.46M, signaling increasing performance

ROIC -1.25% (Source: FMP key-metrics). Below the 5% partial-credit threshold. Score: 0 of 2. The 5% and 10% cutoffs anchor to typical US weighted-average cost of capital. Below 5% indicates the company is not generating returns above its likely cost of capital under this definition of invested capital. Invested capital here includes equity, non-current liabilities (pension obligations, deferred taxes, lease obligations), and short-term debt. Cash is not subtracted. Companies with substantial float, lease portfolios, or cash holdings will score lower under this definition than under narrower operating-capital definitions. See methodology.

Lifecore Biomedical, Inc.'s 3-year revenue CAGR of 5.02% is positive, indicating growing revenue over the past 3 years

Lifecore Biomedical, Inc. had revenue growth in 3 out of 5 years, indicating consistent revenue performance

Lifecore Biomedical, Inc. had positive ROE in only 1 out of 5 years, indicating inconsistent returns on equity

Lifecore Biomedical, Inc. has insufficient data to evaluate this check.

Lifecore Biomedical, Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails

Lifecore Biomedical, Inc. is overvalued relative to its fair value price of 0.00 based on EBITDA multiple model

Lifecore Biomedical, Inc. has an EV/EBITDA ratio of 46.94x, which exceeds the 20.00x threshold, indicating the stock may be overvalued relative to its operating earnings

Lifecore Biomedical, Inc. is overvalued relative to its fair value price of -6.55 based on Earnings Fair Value model

Lifecore Biomedical, Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails

Lifecore Biomedical, Inc. has a price-to-book ratio of 10.88x, which exceeds the 5.00x threshold, indicating the stock may be overvalued relative to its book value

Lifecore Biomedical, Inc. has a price-to-sales ratio of 1.43x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue